Nodal Involvement: Positive about the Role of the Recurrence Score in Estrogen Driven Breast Cancer?

Ítems similars

• New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
  per: Paplomata, Elisavet, et al.
  Publicat: (2013)
• 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
  per: Turashvili, Gulisa, et al.
  Publicat: (2017)
• Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
  per: Makower, Della, et al.
  Publicat: (2021)
• The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
  per: Ahn, Sung Gwe, et al.
  Publicat: (2013)
• Physician Survey of the Effect of the 21-Gene Recurrence Score Assay Results on Treatment Recommendations for Patients With Lymph Node–Positive, Estrogen Receptor–Positive Breast Cancer
  per: Oratz, Ruth, et al.
  Publicat: (2011)